Preliminary Program - Thursday, May 30

Print
Please click on the relevant day to view the applicable detailed program. To view the program overview, please click here

 

  Thursday, May 30    
Wednesday, May 29 Friday, May 31 Saturday, June 1
Thursday, May 30, 2019
 
BREAKFAST IN FLORENCE
 
HALL A
07:30-8:30
NATIONAL SESSION | UNITED ARAB EMIRATES
Chairpersons
 
   TBA
In parallel
HALL B
07:30-8:30
NATIONAL SESSION | ISRAEL
Chairpersons
 
 
Non visualization of the fetal gallbladder: does it really matter?
Ron Bardin
 
Lethal vs. Non-lethal skeletal displasia
Israel Maizner
 
Personalized obstetrics:
Pre-labor ultrasound risk assessment for the prediction of obstructed labor
Sharon Perlman
 
Medical errors in scanning: Several characteristics - can we avoid some of them?
Alon Shrim
 
From Ultrasound findings to targeted genetic testing - new insights
Yinon Gilboa
In parallel
HALL C
07:30-8:30
NATIONAL SESSION | CANADA
Chairpersons
 
   TBA
In parallel
HALL D
07:30-8:30
NATIONAL SESSION | ITALY
Chairpersons
 Ester Vitacolonna, Italy | Elisabetta Torlone, Italy
 
Planning pregnancy in pregestational diabetes: The Italian experience of educational camps for type diabetic women
Natalia Visalli
 
Results after ten years of clinical activities in a 3rd level Hospital Centre 
Basilio Pintaudi
 
General suggestions for physical activity during pregnancy of women with pre-gestational and gestational diabetes
Stefano Balducci
 
Hemodynamic evaluation in pregnant women with pregestational and gestational diabetes
Serena Ottanelli
 
Hemodynamic evaluation in pregnant women with diabetes type 1 and 2
Federico Mecacci
 
Diagnosis of GDM in Italy: Criticism and solutions
Ester Vitacolonna
 
Conclusions
Giorgio Mello
In parallel
HALL E
07:30-8:30
NATIONAL SESSION | POLAND: Polish Society of Gynecologists and Obstetricians
Chairpersons
 TBA
  Diabetes in pregnancy - Polish cohort study
Dorota Bomba-Opon

Association between maternal and fetal hemodynamic parameters
Przemyslaw Kosinski

Umbilical and placental vascularization assessment in pregnancies complicated by hypertension and diabetes
Christopher Kobierzycki

The role of transplacental nutrient transport in the pathogenesis of intrauterine fetal growth disorders
Pawel Stanirowski

Placenta praevia - risk factor for fetal growth abnormalities
Michal Lipa
 
HALL A
08:30-09:00
BUON GIORNO FIRENZE – WAKING UP TO INNOVATIONS AND INVENTIONS
Discussant
TBA
 
Innovative New Technologies; Blood Glucose measurement – The Non Invasive Continuous Glucose solution
Eran Hadar
, Israel
 
HALL A
09:00-10:45
PLENARY SESSION 2 | THE NON COMMUNICABLE DISEASE GLOBAL EPIDEMIC – IT’S ALL ABOUT THE MOTHER, THE OFFSPRING AND FUTURE GENERATIONS
Chairpersons
Gian Carlo Di Renzo, Italy | TBA
 
Time to bring Maternal and Offspring's Health to the forefront of the NCD agenda
TBA

The FIGO Overview
Anil Kapur, India
 
Adolescent and preconception periods as opportunities for intervention
TBA
 
Predicting mental disease – Convergence of placental biology, pregnancy complications and genetic risk for Schizophrenia
Gianluca Ursini, USA
 
Pregnancy and NCD - Show me the DOH: the prevalence and impact of Diabetes, Obesity and Hypertension in isolation or combination on perinatal outcomes
TBA

 
THE FIGO HAP DECLARATION
FIGO Hypertension and Pregnancy 1st Trimester Prediction and Prevention of PET
  The FIGO NCD Initiative – FIGO's response to the global challenge of the NCD pandemic
Moshe Hod, Israel
 
The HAP guidelines
Liona Poon, Hong Kong
10:45-11:15
Coffee and Refreshment Break
 
HALL A
11:15-12:35
PLENARY SESSION 3 | HYPERGLYCEMIA IN PREGNANCY (HIP) – FROM GLOBAL CONSENSUS TO GLOBAL IMPLEMENTATION
Chairpersons
 TBA
 
Controversies in GDM – Why and Whom to blame?
Yariv Yogev, Israel
 
Controversies in GDM - Is the US ready to accept a change in the Diagnostic Criteria for GDM?
Vincenzo Berghella, USA
 
Relevance of South Asia in achieving objectives of the FIGO GDM initiative
TBA
 
Ending the dispute / Analysis of the cost-effectiveness of carrying out GDM Universal diagnosis – The FIGO model
Anil Kapur, India
 
HALL A
12:35-14:00
PLENARY SESSION 4 | FROM PREGNANCY COMPLICATIONS TO AFTER PREGNANCY HEALTH
Pregnancy outcome as a ‘free of charge’ population screening of future NCD
Chairpersons
 Anil Kapur, India | Annunziata Lapolla, Italy
 
Are pregnancy hyperglycemia and hypertension markers for premature cardiovascular disease in women? The public health implications
Ravi Retnakaran, Canada
 
From DIP to DAP
Kaberi Dasgupta, Canada
 
The long-term impact of medical complications in pregnancy: a window into maternal and fetal future health
Eyal Sheiner, Israel
 
Long term maternal cardiovascular health after preeclampsia
TBA

Premature cardiovascular disease in women - the role of pregnancy complications
Jagat Narula, USA
 

14:00-15:00
Lunch Break
 
HALL A
15:00-16:30
SESSION 5A | MATERNAL: EMERGING INFECTIONS
Chairpersons
 Michael Paidas, USA | TBA
 
Zika Virus
Eduardo Fonseca, Brazil
 
CMV
Yves Ville, France
 
Perinatal CMV: Current and Emerging Therapeutic approaches
Michael Paidas, USA
 
The role of microbiota in Neonatal Infections
TBA
 
GBS
Gian Carlo di Renzo, Italy
In Parallel
HALL B
15:00-16:30
SESSION 5B | FETAL: STILLBIRTH PREVENTION
Chairpersons
TBA
 
The importance of maternal nutrition
Irene Cetin, Italy
 
Stillbirth and fetal growth
TBA
 
Gene testing for identification of high risk women
Serena Simeone, Italy
 
An integrated approach to fetal growth restriction
TBA

Prevention through improved surveillance: the Growth Assessment Protocol 
TBA


In Parallel
HALL C
15:00-16:30
SESSION 5C | THE GAME CHANGERS: MEGA STUDIES: THE ASPRE STUDY
Chairpersons
 Liona Poon, Hong Kong
 
Checklist-based screening vs. biomarker approach screening for preeclampsia
Neil O'Gorman, France
 
Effective prevention of preeclampsia and factors that influence the treatment effect of aspirin
Liona Poon, Hong Kong
 
Prevention of preeclampsia: Impact on perinatal morbidity and mortality
TBA
 
Is first trimester screening and prevention of preeclampsia cost effective?
TBA
 
Can the ASPRE approach be implemented elsewhere?
Liona Poon, Hong Kong
In Parallel
HALL D
15:00-16:30
SESSION 5D | THE ITALIAN EXPERIENCE: INNOVATIONS AND INVENTIONS
Chairpersons
 Annunziata Lapolla, Italy | TBA
 
MySweetGestation and MyDGMoving: What about?
Andrea Tumminia, Italy
 
Telemedicine in GDM care
TBA
 
Continuous subcutaneous insulin infusion during delivery
TBA
 
Giuno 3.0 an educational project for the team of diabetes and pregnancy
Graziano Di Cianni, Italy
 
Innovative clinical pathways for obese pregnant women: design and feasibility of the Padua project
TBA
In Parallel
HALL E
15:00-16:30
SESSION 5E | HOT TOPICS IN NEONATAL MEDICINE
Chairpersons
TBA
  Inventions, innovations, winnovations - Stem Cell Therapy for mother and offspring
TBA

Genetic susceptibility to neonatal sepsis
TBA

New modes of neonatal mechanical ventilation
TBA

Antenatal steroids: trending issues
TBA

Brain imaging during follow-up of at risk neonates
TBA
 
HALL A
16:30-18:00
SESSION 6A | GROWTH AND BIRTH WEIGHT STANDARDS
Chairpersons
 Gerard Visser, The Netherlands
 
Optimal birthweight – what should we be aiming for?  
Gerard Visser, The Netherlands
 
The WHO fetal growth standard
Torvid Kiserud, Norway
 
The Intergrowth growth standard
TBA
 
The NIH/NICHD fetal growth studies on ethic variation
TBA
 
Customized growth charts – global application
TBA
In Parallel
HALL B
16:30-18:00
SESSION 6B | THE OMICS AND PERINATAL MEDICINE
Chairpersons
 Diogo Ayres De Campos, Portugal
 
Placentome to syndrome - the crooked path leading from pathological placentas to the great obstetrical syndromes
Amir Aviram, Israel
 
Genomics – small RNAs
Noam Shomron, Israel
 
Microbiomics
TBA
 
Connecting the omics to physiopathology of GDM
Annunziata Lapolla, Italy
 
Monogenic autosomal dominant diabetes in pregnancy
Angela Napoli, Italy
 In Parallel  Hall C
16:30-18:00
SESSION 6C | THE GENOME AND PERINATAL MEDICINE CFDNA TESTING
Chairpersons
TBA
  cfDNA screening in clinical practice and results of an updated meta-analysis in singleton and twin pregnancy
Maria del Mar Gil, Spain

cfDNA testing: technology and biology
Maximillian Schmid, Germany

cfDNA testing beyond common aneuploidy
Francesca Grati, Italy
 In Parallel  Hall D
16:30-18:00
SESSION 6D | MANAGING DATA, NETWORKS AND COST EFFECTIVENESS
Chairpersons
TBA
  How we can use networks to implement research and quality change
TBA

Continuum of care / health system challenges and strategies for improving postpartum follow up of women with hyperglycemia and hypertension in pregnancy
TBA
 
HALL A
18:00-18:30
BUONA SERA FIRENZE – TAKE HOME MESSAGE – CAN RESEARCH ERRATUMS BE PREVENTED
Discussant:
TBA
 
The Microbiome as a predictive tool of pregnancy complications
Omry Koren, Israel
 

Placental Proteome and Pregnancy Complications
Paolo Fiorina, Italy